From population to public institutions: what needs to be changed to benefit from the full value of vaccination

References

• Regnier SA , Huels J . Drug versus vaccine investment: A modelled comparison of economic incentives. Cost Eff Resour Alloc. 2013; 11(1): 23.
   Google Scholar
• Zaidman C , Roussel R , Le Garrec MA , Bouvet M , Solard J , Mikou M . National health accounts in 2013 [Les Comptes nationaux de la santé en 2013]. 2014; Paris: Direction de la recherche, des études, de l'évaluation et des statistiques (DREES).
   Google Scholar
• Italian Medicines Agency. Drug use in Italy. National report 2013 [L'uso dei Farmaci in Italia. Rapporto nazionale anno 2013]. 2013. Available from: http://www.agenziafarmaco.gov.it/it/content/luso-dei-farmaci-italia-rapporto-osmed-2013 [cited 28 November 2014].
   Google Scholar
• EFPIA. Health & wealth: Time for Europe to look forward 2013. Available from: http://www.efpia-annualreview.eu/2013/chapters/health-wealth-time-for-europe-to-look-forward [cited 29 November 2014].
   Google Scholar
• Sahoo A . Vaccines 2011: Market analysis, key players and critical trends in a fast-changing industry. 2011; Rockville, MD: Kalorama Information.
   Google Scholar
• Berman S , Giffin RB . Global perspectives on vaccine financing. Expert Rev Vaccines. 2004; 3(5): 557–62.
   Google Scholar
• Whitehead P , Pasternak A . Lessons learned: New procurement strategies for vaccines. 2002; Chicago, IL: Mercer Management Consulting, Inc.. Final Report to the GAVI Board.
   Google Scholar
• World Health Organisation. Health topics: Disease outbreaks 2015. Available from: http://www.who.int/topics/disease_outbreaks/en/ [cited 20 March 2015].
   Google Scholar
• Centers for Disease Control and Prevention. Increased transmission and outbreaks of measles – European Region, 2011. MMWR. 2011; 60(47): 1605–10.
   Google Scholar
• Bloom DE , Canning D , Weston M . The value of vaccination. World Econ. 2005; 6(3): 15–35.
   Google Scholar
• Wicker S , Maltezou HC . Vaccine-preventable diseases in Europe: Where do we stand?. Expert Rev Vaccines. 2014; 13(8): 979–87.
   Google Scholar
• Plotkin SA . The pertussis problem. Clin Infect Dis. 2014; 58(6): 830–3.
   Google Scholar
• Dube E , Vivion M , MacDonald NE . Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: Influence, impact and implications. Expert Rev Vaccines. 2015; 14(1): 99–117.
   Google Scholar
• Gangarosa EJ , Galazka AM , Wolfe CR , Phillips LM , Gangarosa RE , Miller E et al. Impact of anti-vaccine movements on pertussis control: The untold story. Lancet. 1998; 351(9099): 356–61.
   Google Scholar
• Flaherty DK . The vaccine-autism connection: A public health crisis caused by unethical medical practices and fraudulent science. Ann Pharmacother. 2011; 45(10): 1302–4.
   Google Scholar
• ECDC. Individual decision-making and childhood vaccination. Meeting Report 2013 Available from: http://ecdc.europa.eu/en/publications/Publications/vaccination-individual-decision-making-and-childhood-vaccination.pdf [cited 28 November 2014].
   Google Scholar
• UNICEF. Tracking anti-vaccination sentiment in eastern European social media networks. 2013. Available from: http://www.unicef.org/ceecis/Tracking_anti-vaccine_sentiment_in_Eastern_European_social_media_networks.pdf [cited 28 November 2014].
   Google Scholar
• World Health Organisation. WHO vaccine-preventable disease monitoring system, 2014 global summary. 2014. Available from: http://apps.who.int/immunization_monitoring/globalsummary [cited 28 November 2014].
   Google Scholar
• World Health Organisation. Measles costs 2013. Available from: http://www.euro.who.int/en/media-centre/sections/press-releases/2013/04/measles-costs [cited 12 December 2014].
   Google Scholar
• Public Health England. Measles notifications (confirmed cases) England and Wales 1995 – 2013 by quarter 2014. Available from: http://webarchive.nationalarchives.gov.uk/20140505192926/http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1195733811358 [cited 29 November 2014].
   Google Scholar
• Carabin H , Edmunds WJ , Gyldmark M , Beutels P , Levy-Bruhl D , Salo H et al. The cost of measles in industrialised countries. Vaccine. 2003; 21(27–30): 4167–77.
   Google Scholar
• Bell C , Lewis M . The economic implications of epidemics old and new. World Econ. 2005; 5(4): 137–74.
   Google Scholar
• Bonanni P , Picazo J , Remy V . The intangible benefits of vaccination – what is the true economic value of vaccination?. J Market Access Health Policy. 26964, doi: http://dx.doi.org/10.3402/jmahp.v3.26964.
   Google Scholar
• Quilici S , Smith R , Signorelli C . The role of vaccination in economic growth. JMAPH. 2015. 3:27044, doi: http://dx.doi.org/10.3402/jmahp.v3.27044 .
   Google Scholar
• Barnighausen T , Bloom DE , Cafiero ET , O'Brien JC . Economic evaluation of vaccination: Capturing the full benefits, with an application to human papillomavirus. Clin Microbiol Infect. 2012; 18(Suppl 5): 70–6.
   Google Scholar
• Barnighausen T , Bloom DE , Cafiero-Fonseca ET , O'Brien JC . Valuing vaccination. Proc Natl Acad Sci USA. 2014; 111(34): 12313–9.
   Google Scholar
• Kotsopoulos N , Connolly MP . Is the gap between micro- and macroeconomic assessments in health care well understood? The case of vaccination and potential remedies. J MarketAccess Health Policy. 2014; 2: 23897, doi: . http://dx.doi.org/10.3402/jmahp.v2.23897 .
   Google Scholar
• Smith RD , Keogh-Brown MR , Barnett T , Tait J . The economy-wide impact of pandemic influenza on the UK: A computable general equilibrium modelling experiment. BMJ. 2009; 339: b4571.
   Google Scholar
• Masignani V , Lattanzi M , Rappuoli R . The value of vaccines. Vaccine. 2003; 21(Suppl 2): S110–3.
   Google Scholar
• Shrestha SS , Wallace GS , Meltzer MI . Modeling the national pediatric vaccine stockpile: Supply shortages, health impacts and cost consequences. Vaccine. 2010; 28(38): 6318–32.
   Google Scholar
• Lee GM , Murphy TV , Lett S , Cortese MM , Kretsinger K , Schauer S et al. Cost effectiveness of pertussis vaccination in adults. Am J Prev Med. 2007; 32(3): 186–93.
   Google Scholar
• Deutsche Welle. Germany moves to cut off vaccine shortage 2012. Available from: http://dw.de/p/16Xyu [cited 20 March 2015].
   Google Scholar
• Corriere della serra Milano. Milan, batch of influenza vaccine recalled. Factory suspected. [Milano, ritirato un carico di vaccini contro l'influenza. L'azienda: sospetta pericolosità]. 2012. Available from: http://milano.corriere.it/notizie/cronaca/12_ottobre_17/vaccini-ritirati-milano-2112288586208.shtml [cited 20 March 2015].
   Google Scholar
• Hirschler B . New flu vaccines offer extra protection - and more profits. 2013. Available from: http://www.reuters.com/article/2013/09/19/us-flu-vaccines-idUSBRE98I0M720130919 [cited 20 March 2015].
   Google Scholar
• Lorot P . Vaccines, an advantage at the service of France [Le vaccin, un atout au service de la france]. 2012; Paris: Institut Choiseul. 84.
   Google Scholar
• Ehreth J . The economics of vaccination from a global perspective: Present and future. 2–3 December, 2004, Vaccines: All things considered, San Francisco, CA, USA. Expert Rev Vaccines. 2005; 4(1): 19–21.
   Google Scholar